We are live on
!
Find out more
CH
CVS Health Portfolio holdings
AUM
$225M
1-Year Est. Return
8.77%
This Fund
S&P 500
This Quarter
Est. Return
-9.44%
1 Year Est. Return
+8.77%
3 Year Est. Return
+48.72%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$149M
AUM Growth
+$34.6M
(+30%)
Cap. Flow
+$47.5M
Cap. Flow
% of AUM
31.89%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
2
Increased
–
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard High Dividend Yield ETF
VYM
|
+$24M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
+$23.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LMDXW
LumiraDx Limited Warrant
LMDXW
|
+$55.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 0.57% |
| 2 | Financials | 0.21% |
Similar funds
CA
BF
PS
CFAM
WSA
CLIP
CWM
HCC
CVS Health's Q1 2022 Portfolio in Review
As of Q1 2022, CVS Health held 6 positions worth $149M, up 30% from $114M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
CVS Health deployed $47.5M of net new capital in Q1 2022, opening 2 new positions. Its largest new stake was Vanguard High Dividend Yield ETF: 215,000 shares worth $24.1M.
By sector, the portfolio is most concentrated in Healthcare at 0.57% of assets, down from 1.1% a quarter earlier, followed by Financials.
On the sell side, the largest reduction was LumiraDx Limited Warrant, an estimated $55.4K trimmed.
- CVS Health's largest Q1 2022 buy was Vanguard High Dividend Yield ETF: 215,000 shares worth $24.1M.
- CVS Health's biggest Q1 2022 reduction was LumiraDx Limited Warrant, cutting an estimated $55.4K.
- CVS Health's ten largest holdings make up 100% of its $149M portfolio in Q1 2022.
- CVS Health opened 2 new positions and closed 0 in Q1 2022.
- CVS Health's portfolio value rose 30% quarter-over-quarter to $149M.
Based on CVS Health's 13F filing for Q1 2022, filed 13 May 2022.